Pharma cold chain logistics is very complex with many stakeholders involved. We all work hard to ensure that pharmaceuticals maintain optimal quality all the way to the patients. At Envirotainer we believe that the best way to reach our common goal is to improve collaboration and mutual understanding across the logistics chain, we call it our eco-system thinking. Here, we share articles with our network that we think could benefit us all.
A New Product Introduction, NPI, is a high-risk operation, being the final stage of years of research and development of a new pharmaceutical.
A New Product Introduction, NPI, is a complex and risky process. Even though approval dates are often not known in advance, transport must take place immediately after approval and must follow the specific requirements of the pharmaceutical. Damaged batches or delays could put the whole product launch at risk and could even have devastating consequences for the company and ultimately the patients. Here are seven steps that quality managers could use as a guide to protect the NPI process and to build operational excellence.
At Envirotainer we have more than 30 years of experience of temperature-controlled air transport. So far, we have helped more than 600 pharmaceutical companies worldwide with both regular shipments and New Product Introductions. In this article, we present what we can do to help you design a successful NPI process and lay the foundation for operational excellence of temperature-controlled shipments. Our experience is that a reliable cold chain is much more than just a container. It is the sum of a combination of products and services that together lead to a successful New Product Introduction.